Maria Jose Inojosa on 20th Jan

Obesity treatment showed effectiveness, Zafgen announced

Zafgen Inc. (NASDAQ: ZFGN), a small biopharmaceutical company specialized in anti-obesity drugs, announced on Wednesday that...

Read More
Melany Mejias on 02nd Dec

A second patient dies in obesity drug trial, Zafgen reports

Portland, Boston – Zafgen Inc. (NASDAQ: ZFGN) reported on Wednesday the second death in an obesity drug trial that aims...

Read More